Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Metaraminol Bitartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Metaraminol Bitartrate, including repackagers and relabelers. The FDA regulates Metaraminol Bitartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Metaraminol Bitartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Metaraminol Bitartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Metaraminol Bitartrate supplier is an individual or a company that provides Metaraminol Bitartrate active pharmaceutical ingredient (API) or Metaraminol Bitartrate finished formulations upon request. The Metaraminol Bitartrate suppliers may include Metaraminol Bitartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Metaraminol Bitartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Metaraminol Bitartrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Metaraminol Bitartrate active pharmaceutical ingredient (API) in detail. Different forms of Metaraminol Bitartrate DMFs exist exist since differing nations have different regulations, such as Metaraminol Bitartrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Metaraminol Bitartrate DMF submitted to regulatory agencies in the US is known as a USDMF. Metaraminol Bitartrate USDMF includes data on Metaraminol Bitartrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Metaraminol Bitartrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Metaraminol Bitartrate suppliers with USDMF on PharmaCompass.
A Metaraminol Bitartrate written confirmation (Metaraminol Bitartrate WC) is an official document issued by a regulatory agency to a Metaraminol Bitartrate manufacturer, verifying that the manufacturing facility of a Metaraminol Bitartrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Metaraminol Bitartrate APIs or Metaraminol Bitartrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Metaraminol Bitartrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Metaraminol Bitartrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Metaraminol Bitartrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Metaraminol Bitartrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Metaraminol Bitartrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Metaraminol Bitartrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Metaraminol Bitartrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Metaraminol Bitartrate suppliers with NDC on PharmaCompass.
Metaraminol Bitartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Metaraminol Bitartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Metaraminol Bitartrate GMP manufacturer or Metaraminol Bitartrate GMP API supplier for your needs.
A Metaraminol Bitartrate CoA (Certificate of Analysis) is a formal document that attests to Metaraminol Bitartrate's compliance with Metaraminol Bitartrate specifications and serves as a tool for batch-level quality control.
Metaraminol Bitartrate CoA mostly includes findings from lab analyses of a specific batch. For each Metaraminol Bitartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Metaraminol Bitartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Metaraminol Bitartrate EP), Metaraminol Bitartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Metaraminol Bitartrate USP).
LOOKING FOR A SUPPLIER?
